New hope for nerve disease: batoclimab safety trial expands

NCT ID NCT07188844

Terminated Disease control Sponsor: Immunovant Sciences GmbH Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 12, 2026 · Updated 2 times

Summary

This study checks the long-term safety of a drug called batoclimab for adults with chronic inflammatory demyelinating polyneuropathy (CIDP), a nerve disorder that causes weakness and numbness. About 108 people who finished an earlier batoclimab study will get weekly injections for up to a year. Researchers will watch for side effects and measure how well the drug controls the disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

autoimmune disease chronic inflammatory demyelinating polyradiculoneuropathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY

Contacts and locations

Locations

Site Number - 1601

Austin, Texas, 78759, United States
Site Number - 1610

Charlotte, North Carolina, 28207, United States
Site Number - 1611

Nicholasville, Kentucky, 40356, United States
Site Number - 1617

Ormond Beach, Florida, 32174, United States
Site Number - 1621

New Haven, Connecticut, 06519, United States
Site Number - 3201

Katowice, Silesian Voivodeship, 40-123, Poland
Site Number - 3206

Lublin, Lublin Voivodeship, 20-701, Poland
Site Number - 3207

Poznan, Greater Poland Voivodeship, 61-731, Poland
Site Number - 3208

Krakow, Lesser Poland Voivodeship, 30-688, Poland
Site Number - 3209

Krakow, Lesser Poland Voivodeship, 31-202, Poland
Site Number - 3210

Lublin, Lublin Voivodeship, 20-064, Poland
Site Number - 4680

Leuven, Vlaams Brabant, 3000, Belgium
Site Number - 6305

Bologna, Emilia-Romagna, 40139, Italy
Site Number - 6307

Milan, Lombardy, 20132, Italy
Site Number - 6309

Rome, Lazio, 00133, Italy
Site Number - 6341

Pátrai, Achaïa, 265 04, Greece
Site Number - 6344

Athens, Attica, 115 25, Greece
Site Number - 6347

Larissa, 41110, Greece
Site Number - 6702

Leipzig, Saxony, 04103, Germany
Site Number - 7750

Buenos Aires, C1199ABB, Argentina
Site Number - 7751

Rosario, Santa Fe Province, S2000DTP, Argentina
Site Number - 7752

San Miguel de Tucumán, T4000AXL, Argentina
Site Number - 7753

Rosario, Santa Fe Province, S2000BZL, Argentina
Site Number - 8400

Constanța, 900591, Romania
Site Number - 8403

Timișoara, Timiș County, 300736, Romania
Site Number - 8501

Belgrade, 11000, Serbia
Site Number - 8603

Prešov, 081 81, Slovakia
Site Number - 9100

Ribeirão Preto, São Paulo, 14048-900, Brazil
Site Number - 9101

Curitiba, Paraná, 81210-310, Brazil
Site Number - 9103

Brasília, Federal District, 70200-730, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.